Walter De Brouwer
Walter De Brouwer is chief scientific officer at Sharecare, the digital health company that helps people manage all their health in one place. De Brouwer joined Sharecare in 2021 as part of its acquisition of doc.ai, a Silicon Valley-based company he co-founded to accelerate digital transformation in healthcare.
In addition to his role as chief science officer, De Brouwer is an adjunct professor at Stanford University School of Medicine’s Clinical Excellence Research Center and CEO of xy.ai, a Harvard University spin-off that uses satellite data to map the impact of the exposome on human health.
Prior to joining Sharecare, De Brouwer was a founding member of Scanadu (later relaunched as InuiHealth), a consumer medical devicemaker that obtained 510(k) FDA clearance for its mobile urine test for urinary tract infection, kidney disease, and pre-gestational diabetes.
De Brouwer currently serves as chair of the Institute of Electrical and Electronics Engineers Standards Association (IEEE-SA) IC19-004-01 Synthetic Control Arms division and is a member of the ROCHE Data Science Coalition, Anthem’s digital leadership, TED, and the American Mathematical Society. He holds a master’s degree in formal linguistics from the University of Ghent, Belgium, and a doctoral degree in computational semantics from the Catholic University of Tilburg, the Netherlands. His interests include 5G cognitive radio, tinyML, quantum computing, federated edge learning, and information theory.